サマリー

核医学の世界市場 2023-2027
Technavioは核医学市場をモニターしており、2022年から2027年の間に8億5789万ドル、予測期間中のCAGRは16.48%で加速して成長すると予測しています。当レポートでは、核医学市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を提供しています。
現在の市場シナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、SPECT/CTハイブリッドイメージングシステムの導入拡大、疾患の早期発見を目的とした核医学の利用拡大、がん患者の増加やオンコロジー市場への投資増加などが牽引しています。
Technavioの核医学市場は以下のようにセグメント化されています：
製品別
- 放射線治療学（Radiotherapeutics
- 機器 SPECT、PET
アプリケーション別
- オンコロジー
- 循環器内科
- 神経学
- その他
地理的景観別
- 北アメリカ
- 亜細亜
- ヨーロッパ
- レスト・オブ・ワールド（ROW）
本調査では、放射性医薬品の潜在的な利益と比較して副作用が少ないことが、今後数年間の核医学市場の成長を促進する主要な理由の1つであるとしています。また、ハイブリッドイメージングの用途を広げるための研究活動の増加や、新しい放射性医薬品の絶え間ない発見と開発が、市場の大きな需要につながると考えられます。
Technavioは、複数の情報源からのデータを、主要パラメータの分析によって調査、合成、総括する方法で、市場の詳細な姿を提示します。核医学市場に関する弊社のレポートは、以下の分野をカバーしています：
- 核医学市場のサイジング
- 核医学市場予測
- 核医学市場の産業分析
Technavioの強固なベンダー分析は、クライアントの市場ポジションを向上させることを目的としており、これに沿って本レポートでは、Bayer AG、Bracco Spa、Cardinal Health Inc.、Eckert and Ziegler AG、ECZACIBASI MONROL NUCLEAR PRODUCTS CO.、Jubilant Pharmova Ltd.など核医学市場の主要ベンダー数社の詳細分析を掲載している、GE Healthcare Technologies Inc.、IBA Radiopharma Solutions、Jubilant Pharmova Ltd.、Koninklijke Philips NV、Lantheus Holdings Inc.、Mallinckrodt Plc、Medi-Radiopharma , Mirion Technologies Inc. Necsa, Novartis AG, Siemens Healthineers AG, Sirtex Medical Pty Ltd., Telix Pharmaceuticals Ltd., Tema Sinergie SpA, およびTTG Imaging Solutions LLC.また、核医学市場の分析レポートには、今後の動向や市場成長に影響を与える課題についての情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/nuclear-medicine-market-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析によって、複数のソースからのデータを調査、合成、要約する方法で、市場の詳細な画像を提示します。また、業界の主要なインフルエンサーを特定することで、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた詳細なベンダー選択方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global nuclear medicine market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global nuclear medicine market 2017 - 2021 ($ million)
o 4.2 Product Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
o 4.3 Application Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Radiotherapeutics - Market size and forecast 2022-2027
o Exhibit 34: Chart on Radiotherapeutics - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Radiotherapeutics - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Radiotherapeutics - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Radiotherapeutics - Year-over-year growth 2022-2027 (%)
o 6.4 Equipment (SPECT and PET) - Market size and forecast 2022-2027
o Exhibit 38: Chart on Equipment (SPECT and PET) - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Equipment (SPECT and PET) - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Equipment (SPECT and PET) - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Equipment (SPECT and PET) - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ million)
o Exhibit 43: Data Table on Market opportunity by Product ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 44: Chart on Application - Market share 2022-2027 (%)
o Exhibit 45: Data Table on Application - Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 46: Chart on Comparison by Application
o Exhibit 47: Data Table on Comparison by Application
o 7.3 Oncology - Market size and forecast 2022-2027
o Exhibit 48: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Oncology - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
o 7.4 Cardiology - Market size and forecast 2022-2027
o Exhibit 52: Chart on Cardiology - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Cardiology - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Cardiology - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Cardiology - Year-over-year growth 2022-2027 (%)
o 7.5 Neurology - Market size and forecast 2022-2027
o Exhibit 56: Chart on Neurology - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Neurology - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Neurology - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Neurology - Year-over-year growth 2022-2027 (%)
o 7.6 Others - Market size and forecast 2022-2027
o Exhibit 60: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Application
o Exhibit 64: Market opportunity by Application ($ million)
o Exhibit 65: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Asia - Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.5 Europe - Market size and forecast 2022-2027
o Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Japan - Market size and forecast 2022-2027
o Exhibit 91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.9 China - Market size and forecast 2022-2027
o Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.10 Germany - Market size and forecast 2022-2027
o Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.11 UK - Market size and forecast 2022-2027
o Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Bayer AG
o Exhibit 115: Bayer AG - Overview
o Exhibit 116: Bayer AG - Business segments
o Exhibit 117: Bayer AG - Key news
o Exhibit 118: Bayer AG - Key offerings
o Exhibit 119: Bayer AG - Segment focus
o 12.4 Bracco Spa
o Exhibit 120: Bracco Spa - Overview
o Exhibit 121: Bracco Spa - Product / Service
o Exhibit 122: Bracco Spa - Key offerings
o 12.5 Cardinal Health Inc.
o Exhibit 123: Cardinal Health Inc. - Overview
o Exhibit 124: Cardinal Health Inc. - Business segments
o Exhibit 125: Cardinal Health Inc. - Key news
o Exhibit 126: Cardinal Health Inc. - Key offerings
o Exhibit 127: Cardinal Health Inc. - Segment focus
o 12.6 Eckert and Ziegler AG
o Exhibit 128: Eckert and Ziegler AG - Overview
o Exhibit 129: Eckert and Ziegler AG - Business segments
o Exhibit 130: Eckert and Ziegler AG - Key news
o Exhibit 131: Eckert and Ziegler AG - Key offerings
o Exhibit 132: Eckert and Ziegler AG - Segment focus
o 12.7 ECZACIBASI MONROL NUCLEAR PRODUCTS CO.
o Exhibit 133: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Overview
o Exhibit 134: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Product / Service
o Exhibit 135: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Key offerings
o 12.8 GE Healthcare Technologies Inc.
o Exhibit 136: GE Healthcare Technologies Inc. - Overview
o Exhibit 137: GE Healthcare Technologies Inc. - Business segments
o Exhibit 138: GE Healthcare Technologies Inc. - Key offerings
o Exhibit 139: GE Healthcare Technologies Inc. - Segment focus
o 12.9 IBA Radiopharma Solutions
o Exhibit 140: IBA Radiopharma Solutions - Overview
o Exhibit 141: IBA Radiopharma Solutions - Business segments
o Exhibit 142: IBA Radiopharma Solutions - Key offerings
o Exhibit 143: IBA Radiopharma Solutions - Segment focus
o 12.10 Jubilant Pharmova Ltd.
o Exhibit 144: Jubilant Pharmova Ltd. - Overview
o Exhibit 145: Jubilant Pharmova Ltd. - Business segments
o Exhibit 146: Jubilant Pharmova Ltd. - Key news
o Exhibit 147: Jubilant Pharmova Ltd. - Key offerings
o Exhibit 148: Jubilant Pharmova Ltd. - Segment focus
o 12.11 Koninklijke Philips NV
o Exhibit 149: Koninklijke Philips NV - Overview
o Exhibit 150: Koninklijke Philips NV - Business segments
o Exhibit 151: Koninklijke Philips NV - Key news
o Exhibit 152: Koninklijke Philips NV - Key offerings
o Exhibit 153: Koninklijke Philips NV - Segment focus
o 12.12 Mallinckrodt Plc
o Exhibit 154: Mallinckrodt Plc - Overview
o Exhibit 155: Mallinckrodt Plc - Business segments
o Exhibit 156: Mallinckrodt Plc - Key news
o Exhibit 157: Mallinckrodt Plc - Key offerings
o Exhibit 158: Mallinckrodt Plc - Segment focus
o 12.13 Medi-Radiopharma
o Exhibit 159: Medi-Radiopharma - Overview
o Exhibit 160: Medi-Radiopharma - Product / Service
o Exhibit 161: Medi-Radiopharma - Key offerings
o 12.14 Necsa
o Exhibit 162: Necsa - Overview
o Exhibit 163: Necsa - Product / Service
o Exhibit 164: Necsa - Key offerings
o 12.15 Novartis AG
o Exhibit 165: Novartis AG - Overview
o Exhibit 166: Novartis AG - Business segments
o Exhibit 167: Novartis AG - Key offerings
o Exhibit 168: Novartis AG - Segment focus
o 12.16 Siemens Healthineers AG
o Exhibit 169: Siemens Healthineers AG - Overview
o Exhibit 170: Siemens Healthineers AG - Business segments
o Exhibit 171: Siemens Healthineers AG - Key news
o Exhibit 172: Siemens Healthineers AG - Key offerings
o Exhibit 173: Siemens Healthineers AG - Segment focus
o 12.17 Sirtex Medical Pty Ltd.
o Exhibit 174: Sirtex Medical Pty Ltd. - Overview
o Exhibit 175: Sirtex Medical Pty Ltd. - Product / Service
o Exhibit 176: Sirtex Medical Pty Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 177: Inclusions checklist
o Exhibit 178: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 179: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 180: Research methodology
o Exhibit 181: Validation techniques employed for market sizing
o Exhibit 182: Information sources
o 13.5 List of abbreviations
o Exhibit 183: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global nuclear medicine market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022-2027 (%)
Exhibits31: Data Table on Product - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Radiotherapeutics - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Radiotherapeutics - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Radiotherapeutics - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Radiotherapeutics - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Equipment (SPECT and PET) - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Equipment (SPECT and PET) - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Equipment (SPECT and PET) - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Equipment (SPECT and PET) - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Chart on Application - Market share 2022-2027 (%)
Exhibits45: Data Table on Application - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Application
Exhibits47: Data Table on Comparison by Application
Exhibits48: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Cardiology - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Cardiology - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Cardiology - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Cardiology - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Neurology - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Neurology - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Neurology - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Neurology - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Application ($ million)
Exhibits65: Data Table on Market opportunity by Application ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Bayer AG - Overview
Exhibits116: Bayer AG - Business segments
Exhibits117: Bayer AG - Key news
Exhibits118: Bayer AG - Key offerings
Exhibits119: Bayer AG - Segment focus
Exhibits120: Bracco Spa - Overview
Exhibits121: Bracco Spa - Product / Service
Exhibits122: Bracco Spa - Key offerings
Exhibits123: Cardinal Health Inc. - Overview
Exhibits124: Cardinal Health Inc. - Business segments
Exhibits125: Cardinal Health Inc. - Key news
Exhibits126: Cardinal Health Inc. - Key offerings
Exhibits127: Cardinal Health Inc. - Segment focus
Exhibits128: Eckert and Ziegler AG - Overview
Exhibits129: Eckert and Ziegler AG - Business segments
Exhibits130: Eckert and Ziegler AG - Key news
Exhibits131: Eckert and Ziegler AG - Key offerings
Exhibits132: Eckert and Ziegler AG - Segment focus
Exhibits133: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Overview
Exhibits134: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Product / Service
Exhibits135: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Key offerings
Exhibits136: GE Healthcare Technologies Inc. - Overview
Exhibits137: GE Healthcare Technologies Inc. - Business segments
Exhibits138: GE Healthcare Technologies Inc. - Key offerings
Exhibits139: GE Healthcare Technologies Inc. - Segment focus
Exhibits140: IBA Radiopharma Solutions - Overview
Exhibits141: IBA Radiopharma Solutions - Business segments
Exhibits142: IBA Radiopharma Solutions - Key offerings
Exhibits143: IBA Radiopharma Solutions - Segment focus
Exhibits144: Jubilant Pharmova Ltd. - Overview
Exhibits145: Jubilant Pharmova Ltd. - Business segments
Exhibits146: Jubilant Pharmova Ltd. - Key news
Exhibits147: Jubilant Pharmova Ltd. - Key offerings
Exhibits148: Jubilant Pharmova Ltd. - Segment focus
Exhibits149: Koninklijke Philips NV - Overview
Exhibits150: Koninklijke Philips NV - Business segments
Exhibits151: Koninklijke Philips NV - Key news
Exhibits152: Koninklijke Philips NV - Key offerings
Exhibits153: Koninklijke Philips NV - Segment focus
Exhibits154: Mallinckrodt Plc - Overview
Exhibits155: Mallinckrodt Plc - Business segments
Exhibits156: Mallinckrodt Plc - Key news
Exhibits157: Mallinckrodt Plc - Key offerings
Exhibits158: Mallinckrodt Plc - Segment focus
Exhibits159: Medi-Radiopharma - Overview
Exhibits160: Medi-Radiopharma - Product / Service
Exhibits161: Medi-Radiopharma - Key offerings
Exhibits162: Necsa - Overview
Exhibits163: Necsa - Product / Service
Exhibits164: Necsa - Key offerings
Exhibits165: Novartis AG - Overview
Exhibits166: Novartis AG - Business segments
Exhibits167: Novartis AG - Key offerings
Exhibits168: Novartis AG - Segment focus
Exhibits169: Siemens Healthineers AG - Overview
Exhibits170: Siemens Healthineers AG - Business segments
Exhibits171: Siemens Healthineers AG - Key news
Exhibits172: Siemens Healthineers AG - Key offerings
Exhibits173: Siemens Healthineers AG - Segment focus
Exhibits174: Sirtex Medical Pty Ltd. - Overview
Exhibits175: Sirtex Medical Pty Ltd. - Product / Service
Exhibits176: Sirtex Medical Pty Ltd. - Key offerings
Exhibits177: Inclusions checklist
Exhibits178: Exclusions checklist
Exhibits179: Currency conversion rates for US$
Exhibits180: Research methodology
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Information sources
Exhibits183: List of abbreviations